CD96 and neoplasm: However, the presence of NK cells is typically reduced in established tumors because of the elevated expression of inhibitory receptors, such as TIGIT, CD96, and TIM3, on tumor-infiltrating NK cells, leading to a substantial impairment of their anti-tumor functionality.66